<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Bryce Foster | Curtis Weiss | Activity</title>
	<link>https://brycefoster.com/members/fridaycart9/activity/</link>
	<atom:link href="https://brycefoster.com/members/fridaycart9/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Curtis Weiss.</description>
	<lastBuildDate>Fri, 12 Jun 2026 19:30:30 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">c6aa95916f458704a738b5d6d62abc3b</guid>
				<title>Curtis Weiss posted an update: The Evolution of GLP-1 Medications in Germany: A [&#133;]</title>
				<link>https://brycefoster.com/activity/p/1520638/</link>
				<pubDate>Sun, 05 Apr 2026 11:43:12 +0000</pubDate>

									<content:encoded><![CDATA[<p>The Evolution of GLP-1 Medications in Germany: A Comprehensive Guide to Treatment, Regulation, and Access</p>
<p>Over the last few years, the landscape of metabolic health and obesity management has gone through a paradigm shift, mostly driven by the emergence of GLP-1 (Glucagon-like peptide-1) receptor agonists. In Germany, a country understood for&hellip;<span class="activity-read-more" id="activity-read-more-1520638"><a href="https://brycefoster.com/activity/p/1520638/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d7f7d4a3869ce5b69529d63702892eb5</guid>
				<title>Curtis Weiss became a registered member</title>
				<link>https://brycefoster.com/activity/p/1520547/</link>
				<pubDate>Sun, 05 Apr 2026 11:20:29 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>